FDA Advisory No.2026-1116: Public Health Warning on Unregistered Devices
A warning issued for unregistered suture needles and other products — verify registration status.
The Philippines manages devices under RA 9711 and AO 2018-0002 (aligned with the AMDD) via CMDN/CMDR, with registration fees currently suspended in phases. Foreign manufacturers must appoint a Local Authorized Representative (LAR) and rely on LTO-licensed importers for distribution.
Confirm the LAR and the LTO-licensed importer
Class A via CMDN; Classes B/C/D via CMDR
CSDT compilation, document legalization, label compliance
Submit to CDRRHR via eServices/email
CMDN/CMDR issued (5-year validity) with renewal and PMS obligations
| Product Class | Timeline | Notes |
|---|---|---|
| Class A (CMDN) | 2 months | Notification-type application; fees currently suspended |
| Classes B / C / D (CMDR) | 6–9 months | Registration-type review; NMPA or other reference-country approval accelerates |
Regulatory Updates
A warning issued for unregistered suture needles and other products — verify registration status.
Improved online submission; monitor acceptance arrangements during the system switchover.
Registration, evaluation and annual maintenance fees updated — adjust budgets accordingly.
Covering SaMD/SiMD/AI-MDSW classification, authorization and life-cycle oversight.
Electronic submission keeps improving — check the website for acceptance arrangements during switchover.
Bidding with expired certificates requires proof of renewal acceptance and payment.
Focus on consistency between local-language labels, IFU and approved registration information.
Integrated online/offline sweeps — purchasers must verify registration numbers and status.
CPRs remain valid pending the FDA decision if renewal is filed and paid within 120 days.
Registration holders must maintain a PMS system and submit AE and periodic reports on time.
Judgement criteria for new categories (software, combination products) further clarified.
Importers should verify certificate status and LTO qualifications in advance.
Registration certificates, authorization chains and importer qualifications are port-check priorities.
Foreign manufacturers must complete registration and post-market duties via local representatives.
Integrated online/offline sweeps; violators face administrative penalties.
Sessions on registration procedures and common rejection reasons for companies and local representatives.
Further lower submission costs — file intensively within the window.
Leveraging ASEAN ACCS/GHWP mechanisms, regional review alignment keeps deepening.
Phased product-traceability coding — exporters should watch data-reporting requirements.
LARs bear statutory duties for submission, post-market reporting and recall coordination.
Renewals take time — prepare and submit 6–12 months in advance.
Procurement and customs can verify certificate authenticity and status.
Consistency between certificate scope and actual production sites is the audit priority.
Tracking global regulatory harmonization as local rules keep aligning internationally.
Claims must match the approved intended use; violations face penalties.
Recall information for specific models/batches — cross-check your on-sale products.
Affected products need supplementary verification or test reports per new versions.
Classification and life-cycle requirements for AI and software products keep evolving.
Bidding requires valid registration certificates and supply qualifications matching registration data.
LOAs, FSCs and similar documents must be legalized before acceptance.
* Sources: official website and announcements of Food and Drug Administration (PFDA, CDRRHR) (Philippine FDA Verification Portal). Click “Official source” to verify.
Case Studies
19 cases in total; for the full list see the Case Studies Overview and filter by Philippines.
Contact Us
Delivered directly by our local team, registrations held by the manufacturer. Get a free initial access assessment.